Modalities
Therapeutic modality entry points — mRNA vaccines, gene & cell therapies, antibodies & ADCs, and hematology. Brief us from the indication down.
Modalities Overview Science
Scientific capabilities
preclinics provides bioanalytics and animal study services for early research, discovery, and development projects — from lead quantification in challenging matrices to tailor-made PK/PD models in a broad range of species. In addition to antibody and biologics expertise, the science portfolio includes mRNA, gene therapy, antibody development, and integrated in vitro/in vivo translational workflows.
Services
Three service areas — preclinical studies, drug discovery & antibody development, and bioanalytical services — complemented by a portfolio of animal-derived products.
Services Overview
Technology
13 technology platforms across molecular & genomic analysis, cell & immunology, and imaging & structural analysis. Interactive selector with detail panels.
Technology Overview
Products
Animal-derived materials from our own facility — antisera, primary cells, and tissue lysates, available from stock.
Products Overview Start a program